Canada markets open in 5 hours 4 minutes

Shandong Xinhua Pharmaceutical Company Limited (XIN.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.6250-0.0050 (-0.79%)
As of 08:05AM CEST. Market open.

Shandong Xinhua Pharmaceutical Company Limited

Chemical Industry Area
Zibo Hi-tech Industry Development Zone
Zibo 255005
China
86 53 3216 6666
https://www.xhzy.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees7,104

Key Executives

NameTitlePayExercisedYear Born
Mr. Tongqing HeChairman & Deputy GM207.79kN/A1970
Mr. Ning HouCFO, Financial Controller & Executive Director165kN/A1974
Mr. Changsheng WeiDeputy GM & Manager of Administrative Personnel DepartmentN/AN/A1971
Mr. Wenhui XuExecutive Director196.02kN/A1977
Mr. Xuesong LiuDeputy General ManagerN/AN/AN/A
Mr. Changqiu CaoCompany SecretaryN/AN/A1970
Mr. Zuxing KouDeputy General ManagerN/AN/A1982
Ms. Haifeng GuoHead of Accounting DepartmentN/AN/AN/A
Mr. Xiaohong HeChief of Finance DepartmentN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.

Corporate Governance

Shandong Xinhua Pharmaceutical Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.